Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 81 member B (FAM81B) is a protein-coding gene localized to the cell nucleus whose precise molecular function remains uncharacterized. FAM81B is associated with differential expression in several cancer types, including breast cancer with PIK3CA mutations (where high FAM81B mRNA correlates with progression-free survival) and mesothelioma (where expression is higher in stroma-poor tumors), suggesting a role as a potential prognostic biomarker. Direct evidence for a role in pathogenesis or as a drug target is lacking. There are no known therapeutic drugs or mechanistic models targeting FAM81B, and its broad molecular classification and biological functions remain to be defined in detail[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 81 member B (FAM81B).